Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy

JACC: Cardiovascular Interventions

Volumn 8, Issue 12, 2015, Pages 1552-1562

  Kereiakes, Dean J ^a   Yeh, Robert W ^b,c   Massaro, Joseph M ^b,d   Driscoll Shempp, Priscilla ^b   Cutlip, Donald E ^b,e   Steg, P Gabriel ^f,g,h,i   Gershlick, Anthony H ^j   Darius, Harald ^k   Meredith, Ian T ^l   Ormiston, John ^m   Tanguay, Jean François ⁿ   Windecker, Stephan ^o   Garratt, Kirk N ^p   Kandzari, David E ^q   Lee, David P ^r   Simon, Daniel I ^s   Iancu, Adrian Corneliu ^t   Trebacz, Jaroslaw ^u   Mauri, Laura ^b,v  

^a The Carl & Edyth Lindner Center for Research & Education   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^h BICHAT HOSPITAL   (France)

ⁱ ROYAL BROMPTON HOSPITAL   (United Kingdom)

^j UNIVERSITY OF LEICESTER   (United Kingdom)

^k VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^l MONASH UNIVERSITY   (Australia)

^m Mercy Hospital   (New Zealand)

ⁿ MONTREAL HEART INSTITUTE   (Canada)

^o UNIVERSITY OF BERN   (Switzerland)

^p Christiana Care   (United States)

^q PIEDMONT HEART INSTITUTE   (United States)

^r STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^t IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^u Jan Pawel II Hospital   (Poland)

^v BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

bare metal stents; drug eluting stents; dual antiplatelet therapy; stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO; PRASUGREL; ANTITHROMBOCYTIC AGENT; METAL;

ADD ON THERAPY; ADULT; ARTICLE; ATTRIBUTABLE RISK; BARE METAL STENT; BLEEDING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEVICE COMPARISON; DOUBLE BLIND PROCEDURE; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PACLITAXEL ELUTING CORONARY STENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIROLIMUS ELUTING CORONARY STENT; STENT THROMBOSIS; TREATMENT DURATION; ZOTAROLIMUS ELUTING CORONARY STENT; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DEVICES; DRUG ELUTING STENT; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTOR; STENT; STROKE; TIME FACTOR; TREATMENT OUTCOME;

CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROPENSITY SCORE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84945531731     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.05.026     Document Type: Article

References (27)

1. G.W. Stone, J.W. Moses, S.G. Ellis, and et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
2. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
3. S. Bangalore, S. Kumar, M. Fusaro, and et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
4. T. Palmerini, G. Biondi-Zoccai, D. Della Riva, and et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
5. M. Sabate, L. Raber, D. Heg, and et al. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials J Am Coll Cardiol Intv 7 2014 55 63
6. G.N. Levine, E.R. Bates, J.C. Blankenship, and et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
7. S. Windecker, P. Kolh, F. Alfonso, and et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 35 2014 2541 2619
8. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
9. L. Mauri, D.J. Kereiakes, R.W. Yeh, and et al. Twelve or 30 months of dual anti-platelet therapy after drug-eluting stents N Engl J Med 371 2014 2155 2166
10. D.J. Kereiakes, R.W. Yeh, J.M. Massaro, and et al. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial JAMA 313 2015 1113 1121
11. A. Badheka, S. Arora, S. Panaich, and et al. Impact on in-hospital outcomes with drug-eluting stents versus bare-metal stents (from 665,804 procedures) Am J Cardiol 114 2014 1629 1637
12. P.S. Douglas, J.M. Brennan, K.J. Anstrom, and et al. Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry J Am Coll Cardiol 53 2009 1629 1641
13. L. Mauri, D.J. Kereiakes, S.L. Normand, and et al. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions Am Heart J 160 2010 1035 1041 1041 e1
14. D.E. Cutlip, S. Windecker, R. Mehran, and et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
15. P.C. Austin Assessing balance in measured baseline covariates when using many-to-one matching on the propensity-score Pharmacoepidemiol Drug Saf 17 2008 1218 1225
16. The GUSTO investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
17. J.M. Nam, and D. Kwon Non-inferiority tests for clustered matched-pair data Stat Med 28 2009 1668 1679
18. G.W. Stone, A. Rizvi, K. Sudhir, and et al. Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial J Am Coll Cardiol 58 2011 19 25
19. W. Wijns, P.G. Steg, L. Mauri, and et al. Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4 year results of the PROTECT randomized trial Eur Heart J 35 2014 2812 2820
20. L.C. McCandless, P. Gustafson, and A. Levy Bayesian sensitivity analysis for unmeasured confounding in observational studies Stat Med 26 2007 2331 2347
21. S.P. Brooks, and A. Gelman General Methods for Monitoring Convergence of Iterative Simulations J Comput Graph Stat 7 1998 434 455
22. G.W. Stone, S.G. Ellis, A. Colombo, and et al. Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program J Am Coll Cardiol Intv 4 2011 530 542
23. K. Yamaji, T. Kimura, T. Morimoto, and et al. Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation Circ Cardiovasc Interv 3 2010 468 475
24. D.E. Cutlip, A.G. Chhabra, D.S. Baim, and et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials Circulation 110 2004 1226 1230
25. R. Chacko, M. Mulhearn, V. Novack, and et al. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting J Am Coll Cardiol Intv 2 2009 498 503
26. M. Takano, M. Yamamoto, and K. Mizuno Two cases of coronary stent thrombosis very late after bare-metal stenting J Am Coll Cardiol Intv 2 2009 1286 1287
27. M.S. Chen, J.M. John, D.P. Chew, D.S. Lee, S.G. Ellis, and D.L. Bhatt Bare metal stent restenosis is not a benign clinical entity Am Heart J 151 2006 1260 1264